One Agent Better for RAS Blockade

ASH 2012 — NEW YORK CITY — The use of two agents to block the renin-angiotensin system (RAS) — as opposed to one — appears to have little benefit and has significant negative effects, a meta-analysis showed.


< Back to Listings